ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,197Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 1802

$588K Total Retail Price of All Prescriptions

Rank: 54 out of 1802

435 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 501 395 1 1
HYDROCODONE-ACETAMINOPHEN 401 182 S3 2 10
LEVOTHYROXINE SODIUM 259 192 3 2
FUROSEMIDE 248 203 4 5
ZOLPIDEM TARTRATE 222 182 5 27
AMLODIPINE BESYLATE 213 193 6 6
OMEPRAZOLE 212 171 7 4
LISINOPRIL 205 158 8 3
HYDROCHLOROTHIAZIDE 180 155 9 8
METFORMIN HCL 177 125 10 11
WARFARIN SODIUM 174 149 11 7
POTASSIUM CHLORIDE 163 142 12 15
GABAPENTIN 139 83 13 16
NEXIUM 135 66 14 50
METOPROLOL TARTRATE 127 120 15 9
ATENOLOL 120 92 16 12
ATORVASTATIN CALCIUM 108 81 17 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 83 18 23
CRESTOR 86 86 19 31
SERTRALINE HCL 85 60 20 20
ALLOPURINOL 83 76 21 24
PREDNISONE 79 61 22 33
DIGOXIN 79 79 22 45
MELOXICAM 77 54 24 59
ADVAIR DISKUS 76 48 25 32
METFORMIN HCL ER 75 33 26 46
TRAMADOL HCL 75 32 26 22
DIOVAN 72 62 28 57
DICLOFENAC SODIUM 71 53 29 93
OXYCODONE HCL 70 22 S2 30 41
METOPROLOL SUCCINATE 70 65 30 13
ALENDRONATE SODIUM 67 67 32 21
PRAVASTATIN SODIUM 67 67 32 19
AMITRIPTYLINE HCL 66 40 R 34 80
LOVASTATIN 64 51 35 25
LANTUS 64 50 35 47
TAMSULOSIN HCL 60 48 37 28
VENTOLIN HFA 59 34 38 125
RANITIDINE HCL 56 34 39 30
CLOPIDOGREL 55 50 40 48
FINASTERIDE 51 51 41 88
POLYETHYLENE GLYCOL 3350 51 40 41 29
TRIAMCINOLONE ACETONIDE 51 44 41 91
LOSARTAN POTASSIUM 50 39 44 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.